SEC Comment Letter for AETHLON MEDICAL INC (AEMD) (CIK 0000882291) (AEMD) — Nov 20, 2019
AETHLON MEDICAL INC (AEMD) (CIK 0000882291)
Date: Nov. 20, 2019 · CIK: 0000882291 · Accession: 0000000000-19-015679
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234712
Letter
November 20, 2019 James B. Frakes Chief Financial Officer Aethlon Medical Inc. 9635 Granite Ridge Drive, Suite 100 San Diego, CA 92123 Re:Aethlon Medical Inc. Registration Statement on Form S-1 Filed November 15, 2019 File No. 333-234712 Dear Mr. Frakes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Paul Fischer at 202-551-3415 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Julie Robinson, Esq.
Show Raw Text
November 20, 2019
James B. Frakes
Chief Financial Officer
Aethlon Medical Inc.
9635 Granite Ridge Drive, Suite 100
San Diego, CA 92123
Re:Aethlon Medical Inc.
Registration Statement on Form S-1
Filed November 15, 2019
File No. 333-234712
Dear Mr. Frakes:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Paul Fischer at 202-551-3415 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Julie Robinson, Esq.